Clinical Trial Update: Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of imatinib in chronic myeloid leukemia patients who relapse after stem cell transplantation. The study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED